Cigna Investments’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,438
Closed -$216K 653
2021
Q4
$216K Sell
1,438
-540
-27% -$72.9K 0.02% 610
2021
Q3
$236K Buy
+1,978
New +$218K 0.02% 647

Other funds holding TNDM

Cigna Investments's TNDM Position: Q1 2022 in Review

Cigna Investments sold out of Tandem Diabetes Care (TNDM) in Q1 2022, closing a stake of 1,438 shares — an estimated $216K sold.

Cigna Investments first reported a position in TNDM in Q3 2021 and held it in 2 quarters. The position peaked at $236K in Q3 2021. 379 funds tracked by Wall St. Rank hold TNDM as of Q1 2022.

  • Cigna Investments reported no remaining Tandem Diabetes Care position as of Q1 2022 after selling out during the quarter.
  • Cigna Investments sold 1,438 Tandem Diabetes Care shares in Q1 2022, an estimated $216K.
  • Cigna Investments first reported a position in Tandem Diabetes Care in Q3 2021 and held it in 2 quarters.
  • Cigna Investments's Tandem Diabetes Care position peaked at $236K in Q3 2021.
  • 379 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2022.

Based on Cigna Investments's 13F filing for Q1 2022, filed 13 May 2022.